Effect of Fluid Status at Week 12 on Visual and Anatomic Outcomes at Week 52 in the VIEW 1 and 2 Trials

Copyright 2016, SLACK Incorporated.

Détails bibliographiques
Publié dans:Ophthalmic surgery, lasers & imaging retina. - 2013. - 47(2016), 3 vom: 03. März, Seite 238-44
Auteur principal: Moshfeghi, Darius M (Auteur)
Autres auteurs: Hariprasad, Seenu M, Marx, Jeffrey L, Thompson, Desmond, Soo, Yuhwen, Gibson, Andrea, Saroj, Namrata, Vitti, Robert, Heier, Jeffrey S
Format: Article en ligne
Langue:English
Publié: 2016
Accès à la collection:Ophthalmic surgery, lasers & imaging retina
Sujets:Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Angiogenesis Inhibitors Drug Combinations Recombinant Fusion Proteins VEGFA protein, human Vascular Endothelial Growth Factor A aflibercept plus... 15C2VL427D Receptors, Vascular Endothelial Growth Factor EC 2.7.10.1 Ranibizumab ZL1R02VT79